Here’s what you should know:
1. Barron’s cites Evercore ISI analyst Umer Raffat saying Valeant management was considering a debt to equity swap. “When you have a debt stack that looks like our debt stack, it’s not – to say it wasn’t on the table wouldn’t be credible. It’s something that we certainly need to think about,” Valeant management said.
2. A debt swap allows a company to reduce its debt while creating a “quick path to gain for unsecured debt holders.” However, the swap would raise Valeant’s total shares diluting earnings.
3. Valeant has approximately $18.2 billion in unsecured debt, with around $9 billion in long-dated notes, Barron’s reports.
4. Mr. Ruffert wrote that Valeant could potential create $300 million on value on a $1 billion swap. He believes Valeant has $9 billion eligible for the debt swap.
More articles on gastroenterology:
GI leader to know: Dr. Michael Thiim of Massachusetts General Hospital
GI center to know: Gastroenterology Associates
5 stats on GI net revenue per case at multispecialty ASCs
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
